Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Rosanne Lane

ResearcherPublications, citations & collaboration network

Rosanne Lane is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 53 works, 6,657 citations, an h-index of 28 and an i10-index of 35.

53
Works
6,657
Citations
28
h-index
35
i10-index

How has Rosanne Lane's publication output changed over time?

ScholarIQpublication output · 2000–2020

Output grew300% over the shown period — from 1 works in 2000 to 4 in 2020.

1
1
1
4
4
20002006201820192020

What are the most-cited papers on Rosanne Lane?

ScholarIQmost cited works
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova, Ella Daly, Madhukar H. Trivedi, Kimberly Cooper, Rosanne Lane, Pilar Lim, Christine Mazzucco, David Hough, Michael E. Thase, Richard C. Shelton, Patricio Molero, Eduard Vieta, Malek Bajbouj, Husseini K. Manji, Wayne C. Drevets, Jaskaran Singh
S116025658. 2019886 CitationsOPEN ACCESS
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
Ella Daly, Madhukar H. Trivedi, Adam Janik, Honglan Li, Yun Zhang, Xiang Li, Rosanne Lane, Pilar Lim, A. Duca, David Hough, Michael E. Thase, John Zajecka, Andrew Winokur, Ilona Divacka, Andrea Fagiolini, Wiesław Jerzy Cubała, István Bitter, Pierre Blier, Richard C. Shelton, Patricio Molero, Husseini K. Manji, Wayne C. Drevets, Jaskaran Singh
S2495708506. 2019779 CitationsOPEN ACCESS
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M. Canuso, Jaskaran Singh, Maggie Fedgchin, Larry Alphs, Rosanne Lane, Pilar Lim, Christine Pinter, David Hough, Gerard Sanacora, Husseini K. Manji, Wayne C. Drevets
S116025658. 2018669 CitationsOPEN ACCESS
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
Maggie Fedgchin, Madhukar H. Trivedi, Ella Daly, Rama Melkote, Rosanne Lane, Pilar Lim, Dawn Vitagliano, Pierre Blier, Maurizio Fava, Michael R. Liebowitz, Arun Ravindran, Raphaël Gaillard, Hans van den Ameele, Sheldon Preskorn, Husseini K. Manji, David Hough, Wayne C. Drevets, Jaskaran Singh
S199972112. 2019597 CitationsOPEN ACCESS
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
Rachel Ochs-Ross, Ella Daly, Yun Zhang, Rosanne Lane, Pilar Lim, Randall L. Morrison, David Hough, Husseini K. Manji, Wayne C. Drevets, Gerard Sanacora, David C. Steffens, Caleb M. Adler, Rupert McShane, Raphaël Gaillard, Samuel T. Wilkinson, Jaskaran Singh
S182891740. 2019477 CitationsOPEN ACCESS

Related on ScholarIQ

Johnson & Johnson (United States)
Institution
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Paper
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
Paper
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Paper
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
Paper
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
Paper
470M+ articles · free account